Geron (GERN) Depreciation & Amortization (CF) (2010 - 2026)
Geron's (GERN) quarterly Depreciation & Amortization (CF) came in at $134000.0 in Q1 2026, up 2.29% year-on-year from $131000.0 in Q1 2025, and up 54.02% quarter-over-quarter from $87000.0 in Q4 2025.
Geron (GERN) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Geron has disclosed Depreciation & Amortization (CF) across 17 years of filings, most recently posting $134000.0 for Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $134000.0, up 2.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $477000.0 (down 15.72% YoY), and the FY2025 annual result was $474000.0, down 13.19% from the prior year.
- Depreciation & Amortization (CF) came in at $134000.0 for Q1 2026 at Geron, up from $87000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $262000.0 in Q2 2024 to a low of $31000.0 in Q3 2024.
- The 5-year median for Depreciation & Amortization (CF) is $111000.0 (2024), against an average of $110823.5.
- Across the five-year window, Depreciation & Amortization (CF) plunged 71.3% in 2024 and soared 312.9% in 2025, its largest moves.
- Geron's Depreciation & Amortization (CF) stood at $80000.0 in 2022, then jumped by 42.5% to $114000.0 in 2023, then rose by 24.56% to $142000.0 in 2024, then tumbled by 38.73% to $87000.0 in 2025, then jumped by 54.02% to $134000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $134000.0 (Q1 2026), $87000.0 (Q4 2025), and $128000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 429,663.65 |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 134,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134,000.00 |
| Mar 31, 2026 | 134,000.00 |
| Dec 31, 2025 | 87,000.00 |
| Dec 31, 2025 | 87,000.00 |
| Sep 30, 2025 | 128,000.00 |
| Sep 30, 2025 | 128,000.00 |
| Jun 30, 2025 | 128,000.00 |
| Jun 30, 2025 | 128,000.00 |
| Mar 31, 2025 | 131,000.00 |
| Mar 31, 2025 | 131,000.00 |
| Dec 31, 2024 | 142,000.00 |
| Dec 31, 2024 | 142,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Jun 30, 2024 | 262,000.00 |
| Jun 30, 2024 | 262,000.00 |
| Mar 31, 2024 | 111,000.00 |
| Mar 31, 2024 | 111,000.00 |
| Dec 31, 2023 | 114,000.00 |
| Dec 31, 2023 | 114,000.00 |